Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma

Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma

The expression and function of CD163 in glioma are not fully understood. In this report, we collected totally 1323 glioma samples from the Chinese Glioma Genome Atlas (CGGA) dataset, including 325 RNA-seq data and 301 mRNA microarray data, and 697 glioma samples from The Cancer Genome Atlas (TCGA) d...

Full description

Bibliographic Details
Main Authors:	Shasha Liu, Chaoqi Zhang, Nomathamsanqa Resegofetse Maimela, Li Yang, Zhen Zhang, Yu Ping, Lan Huang, Yi Zhang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2019-07-01
Series:	OncoImmunology
Subjects:	cd163 glioma immunotherapy prognosis immune checkpoint
Online Access:	http://dx.doi.org/10.1080/2162402X.2019.1601478

Similar Items

Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis
by: Qiang Zhang, et al.
Published: (2020-06-01)

Corrigendum: Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis
by: Qiang Zhang, et al.
Published: (2020-10-01)

Large-scale analysis reveals the specific clinical and immune features of B7-H3 in glioma
by: Chaoqi Zhang, et al.
Published: (2018-11-01)

Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma
by: Yongliang Yuan, et al.
Published: (2019-07-01)

CD163 and its role in inflammation
by: Lech Chyczewski, et al.
Published: (2011-10-01)

Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
by: Farag AGA, et al.
Published: (2020-06-01)

Prospects for predicting the course of nodular sclerosis Hodgkin lymphoma by morphometric analysis of CD163-positive macrophages
by: M. S. Minaev, et al.
Published: (2021-04-01)

CD48 is a key molecule of immunomodulation affecting prognosis in glioma
by: Zou C, et al.
Published: (2019-05-01)

Prognostic significance of CD163+ tumor-associated macrophages in colorectal cancer
by: Tao Xue, et al.
Published: (2021-06-01)

Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease
by: Yoshihiro Azuma, et al.
Published: (2020-04-01)

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
by: Sara Bravaccini, et al.
Published: (2019-04-01)

Immune Checkpoint Inhibitors in Human Glioma Microenvironment
by: Amina Ghouzlani, et al.
Published: (2021-07-01)

CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial
by: Anne Gomez-Brouchet, et al.
Published: (2017-09-01)

Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis
by: Yue Zhang, et al.
Published: (2021-07-01)

Effect of compounds on the purification and antibody preparation of the extracellular domain fragment of the receptor CD163
by: Qi Wen-Bao, et al.
Published: (2011-03-01)

A novel gene signature based on five immune checkpoint genes predicts the survival of glioma
by: Wei Zhang, et al.
Published: (2021-02-01)

Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: a prospective study
by: Su Longxiang, et al.
Published: (2012-09-01)

Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses
by: Qianqian Liu, et al.
Published: (2019-11-01)

miR-4262, low level of which predicts poor prognosis, targets proto-oncogene CD163 to suppress cell proliferation and invasion in gastric cancer
by: Zhang H, et al.
Published: (2019-01-01)

CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas
by: Shengchao Xu, et al.
Published: (2021-09-01)

Scavenger Receptor CD163 and Its Biological Functions
by: Gabriela Onofre, et al.
Published: (2009-01-01)

Macrophage CD163 expression is neuroprotective in subarachnoid hemorrhage patients
by: Chen, Ruiya
Published: (2016)

Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children
by: Jintanat Ananworanich, et al.
Published: (2015-07-01)

CTLA-4 correlates with immune and clinical characteristics of glioma
by: Fangkun Liu, et al.
Published: (2020-01-01)

CD163ΔSRCR5 MARC-145 Cells Resist PRRSV-2 Infection via Inhibiting Virus Uncoating, Which Requires the Interaction of CD163 With Calpain 1
by: Piao Yu, et al.
Published: (2020-01-01)

Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment
by: Nan Zhang, et al.
Published: (2021-08-01)

The CD112R/CD112 axis: a breakthrough in cancer immunotherapy
by: Taofei Zeng, et al.
Published: (2021-09-01)

The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer
by: Guozeng Xu, et al.
Published: (2021-08-01)

Targeting Immune Modulators in Glioma While Avoiding Autoimmune Conditions
by: Lynn Bitar, et al.
Published: (2021-07-01)

CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas
by: Depei Li, et al.
Published: (2021-03-01)

Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas
by: Zenghui Qian, et al.
Published: (2018-06-01)

CD163 promotes hematoma absorption and improves neurological functions in patients with intracerebral hemorrhage
by: Wen-jing Xie, et al.
Published: (2016-01-01)

Regular Training Increases sTWEAK and Its Decoy Receptor sCD163–Does Training Trigger the sTWEAK/sCD163-Axis to Induce an Anti-Inflammatory Effect?
by: Robert Schönbauer, et al.
Published: (2020-06-01)

Lipopolysaccharide Downregulates CD163 Expression to Inhibit PRRSV Infection via TLR4-NF-κB Pathway
by: Zhenbang Zhu, et al.
Published: (2020-03-01)

CD163 as a Potential Biomarker of Monocyte Activation in Ischemic Stroke Patients
by: Rosaria Greco, et al.
Published: (2021-06-01)

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
by: Sotirios P. Fortis, et al.
Published: (2017-04-01)

Zelluläre Regulation und klinische Aspekte des monocyten-/macrophagenspezifischen Proteins CD163
by: Timmermann, Meike
Published: (2005)

Targeting of CD163<sup>+</sup> Macrophages in Inflammatory and Malignant Diseases
by: Maria K. Skytthe, et al.
Published: (2020-07-01)

Specific clinical and immune features of CD68 in glioma via 1,024 samples
by: Wang L, et al.
Published: (2018-11-01)

Drug Trafficking into Macrophages via the Endocytotic Receptor CD163
by: Jonas Heilskov Graversen, et al.
Published: (2015-06-01)